Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Katarzyna Gaweł, Krzysztof Dąbkowski, Iwona Zawada & Teresa Starzyńska. (2022) Progression risk factors of ulcerative proctitis. Scandinavian Journal of Gastroenterology 57:12, pages 1406-1411.
Read now
Read now
Federica Giachero, Andreas Jenke & Matthias Zilbauer. (2021) Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology 17:8, pages 871-881.
Read now
Read now
Jose María Huguet, Luis Ferrer-Barceló, Patrícia Suárez, Cecilia Albert, Lara Gonzalez, Genesis Castillo, Carlos Boix, Laura García, Juan Gallego & Javier Sempere. (2018) Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?. Scandinavian Journal of Gastroenterology 53:10-11, pages 1286-1290.
Read now
Read now
Krisztina B Gecse & Peter L Lakatos. (2014) Ulcerative proctitis: an update on the pharmacotherapy and management. Expert Opinion on Pharmacotherapy 15:11, pages 1565-1573.
Read now
Read now
Articles from other publishers (37)
Mathieu Uzzan, Maria Nachury, Alexandre Nuzzo, Aurélien Amiot, Bénédicte Caron, Alban Benezech, Anthony Buisson, Guillaume Bouguen, Catherine Le Berre, Catherine Reenaers, Guillaume Le Cosquer, Guillaume Savoye, Maeva Charkaoui, Mathias Vidon, Lucas Guillo, Mathurin Fumery, Laurent Peyrin-Biroulet, Julien Kirchgesner, Yoram Bouhnik, Mathurin Fumery, Clara Yzet, Franck Brazier, Lore Billiauws, Yoram Bouhnik, Alexandre Nuzzo, Aurélien Amiot, Franck Carbonnel, Clément Bresteau, Antoine Meyer, Christophe Bellanger, Maria Nachury, Pauline Wils, Pierre Desreumaux, Julien Branche, Romain Gérard, Julie Assaraf, Charlotte Gagnière, Mathieu Uzzan, Laurent Beaugerie, Harry Sokol, Philippe Seksik, Anne Bourrier, Julien Kirchgesner, Paul McLellan, Guillaume Le Cosquer, Cyrielle Gilletta, Bénédicte Caron, Laurent Peyrin-Biroulet, Thomas Guilmoteau, Marie Dodel, Dilek Coban, Yoram Bouhnik, Mathilde Cohen, Carmen Stefanescu, Xavier Treton, Lucas Guillo & Mélanie Serrero. (2023) Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID. Journal of Crohn's and Colitis.
Crossref
Crossref
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon W. Moran, Sudheer K. Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K. MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma & Vipul Jairath. (2023) Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary Pharmacology & Therapeutics.
Crossref
Crossref
Massimo Martinelli, Flora Fedele, Claudio Romano, Marina Aloi, Paolo Lionetti, Patrizia Alvisi, Serena Arrigo, Luca Bosa, Matteo Bramuzzo, Giulia D'Arcangelo, Valeria Dipasquale, Enrico Felici, Maurizio Fuoti, Simona Gatti, Francesco Graziano, Maria Teresa Illiceto, Flavio Labriola, Lorenzo Norsa, Maria Pastore, Luca Scarallo, Caterina Strisciuglio, Giovanna Zuin, Erasmo Miele & Annamaria Staiano. (2023) Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group. Digestive and Liver Disease.
Crossref
Crossref
Pauline Lemmens, Edouard Louis, Wouter Van Moerkercke, Lieven Pouillon, Michael Somers, Harald Peeters, Stijn Vanden Branden, Julie Busschaert, Filip Baert, Anneline Cremer, Philippe Potvin, Sophie Dewit, Arnaud Colard, Jo Swinnen, Guy Lambrecht, Christophe Claessens, Barbara Willandt, Pieter Dewint, Evi Van Dyck, Joao Sabino, Séverine Vermeire & Marc Ferrante. (2023) Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study. Clinical Gastroenterology and Hepatology.
Crossref
Crossref
Nazire E. Albayrak & Alexandros D. Polydorides. (2022) Characteristics and Outcomes of Left-sided Ulcerative Colitis With a Cecal/Periappendiceal Patch of Inflammation. American Journal of Surgical Pathology 46:8, pages 1116-1125.
Crossref
Crossref
Carsten Schmidt, Bernd Bokemeyer, Andreas Lügering, Dominik Bettenworth, Niels Teich, Imma Fischer, Leonie Hammer, Stefanie Kolterer, Stefan Rath & Andreas Stallmach. (2022) Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study. International Journal of Colorectal Disease 37:2, pages 485-493.
Crossref
Crossref
Georgios Michalopoulos & Konstantinos Karmiris. (2022) When disease extent is not always a key parameter: Management of refractory ulcerative proctitis. Current Research in Pharmacology and Drug Discovery 3, pages 100071.
Crossref
Crossref
Jongwook Yu, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2021) Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis. Gut and Liver 15:6, pages 858-866.
Crossref
Crossref
Jongbeom Shin, Sung Min Kong, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang & Young-Ho Kim. (2021) Clinical Significance of Residual Nonrectal Inflammation in Ulcerative Colitis Patients in Clinical Remission. Gut and Liver 15:3, pages 401-409.
Crossref
Crossref
Hao Wu, Delin Tian, Hao Cai, Renjie Gong, Kaixiao Kun & Can-Xia Xu. (2021) Predictors of clinical relapse in patients with new-onset inflammatory bowel disease: A retrospective single-center study. Libyan Journal of Medical Sciences 5:2, pages 42.
Crossref
Crossref
Maryam Alkhatry, Ahmad Al-Rifai, Vito Annese, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul Nathwani, Mazen S Taha & Jimmy K Limdi. (2020) First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus. World Journal of Gastroenterology 26:43, pages 6710-6769.
Crossref
Crossref
Rélana NowackiAnita VreugdenhilFreddy Kokke. (2020) Successful Treatment of Refractory Ulcerative Proctitis in a Pediatric Patient Using Topical Tacrolimus. JPGN Reports 1:2, pages e012.
Crossref
Crossref
Evelyne Dubois, Annick Moens, Rob Geelen, João Sabino, Marc Ferrante & Séverine Vermeire. (2020) Long‐term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort. United European Gastroenterology Journal 8:8, pages 933-941.
Crossref
Crossref
Lorenzo Bertani, Giorgia Bodini, Maria Gloria Mumolo, Nicola de Bortoli, Linda Ceccarelli, Leonardo Frazzoni, Gherardo Tapete, Eleonora Albano, Maria Corina Plaz Torres, Massimo Bellini, Edoardo Savarino, Vincenzo Savarino, Santino Marchi & Francesco Costa. (2019) Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis. Digestive Diseases and Sciences 65:8, pages 2397-2402.
Crossref
Crossref
Mitchell R.K. L. Lie, Joany E. Kreijne, Gerard Dijkstra, Mark Löwenberg, Gert van Assche, Rachel L. West, Desiree van Noord, Andrea E. van der Meulen - de Jong, Bas Oldenburg, Rianne J. Zaal, Bettina E. Hansen, Annemarie C. de Vries & Christien Janneke van der Woude. (2020) No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis. Clinical Gastroenterology and Hepatology 18:8, pages 1777-1784.e2.
Crossref
Crossref
Gerhard Rogler & Luc Biedermann. 2020. Chronisch-entzündliche Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen
87
94
.
Yun Qiu, Baili Chen, Yufei Li, Shanshan Xiong, Shenghong Zhang, Yao He, Zhirong Zeng, Shomron Ben-Horin, Minhu Chen & Ren Mao. (2019) Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study. BMC Gastroenterology 19:1.
Crossref
Crossref
Jenna L. Koliani-Pace & Corey A. Siegel. (2019) Prognosticating the Course of Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 29:3, pages 395-404.
Crossref
Crossref
Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Tzu-Chi HsuHorng-Yuan Wang. (2019) Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response. Medicine 98:21, pages e15748.
Crossref
Crossref
Colin B. Peirce & Matthew F. Kalady. 2019. Fundamentals of Anorectal Surgery. Fundamentals of Anorectal Surgery
531
554
.
Dong Suk Shin, Jae Hee Cheon, Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim & Won Ho Kim. (2018) Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis. Digestive Diseases and Sciences 63:11, pages 3097-3104.
Crossref
Crossref
Alessia Butera, Massimo Sanchez, Annamaria Pronio, Antonello Amendola, Daniela De Nitto, Nazzareno Di Carlo, Roberto Lande, Loredana Frasca, Francesco Borrini, Roberta Pica & Monica Boirivant. (2018) CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis. Frontiers in Immunology 9.
Crossref
Crossref
Yong Sung Choi, Wan Jung Kim, Jong Kyu Kim, Do Sun Kim & Doo Han Lee. (2018) Efficacy of topical 5‐aminosalicylate monotherapy in patients with ulcerative proctitis with skip inflammation. Journal of Gastroenterology and Hepatology 33:6, pages 1200-1206.
Crossref
Crossref
Guillaume Pineton de Chambrun, Barbara Tassy, Laura Kollen, Gaspard Dufour, Jean-Christophe Valats, Michael Bismuth, Natalie Funakoshi, Fabrizio Panaro & Pierre Blanc. (2018) Refractory ulcerative proctitis: How to treat it?. Best Practice & Research Clinical Gastroenterology 32-33, pages 49-57.
Crossref
Crossref
Taku KobayashiTadakazu HisamatsuYasuo SuzukiHaruhiko OgataAkira AndohToshimitsu ArakiRyota HokariHideki IijimaHiroki IkeuchiYoh IshiguroShingo KatoReiko KunisakiTakayuki MatsumotoSatoshi MotoyaMasakazu NagahoriShiro NakamuraHiroshi NakaseTomoyuki TsujikawaMakoto SasakiKaoru YokoyamaNaoki YoshimuraKenji WatanabeMiiko KatafuchiMamoru WatanabeToshifumi Hibi. (2018) Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries. Intestinal Research 16:2, pages 168.
Crossref
Crossref
Shingo Kato, Akira Ishibashi, Kazuhito Kani & Koji Yakabi. (2018) Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository. Digestion 97:1, pages 59-63.
Crossref
Crossref
A Hochart, C Gower-Rousseau, H Sarter, M Fumery, D Ley, C Spyckerelle, L Peyrin-Biroulet, J-E Laberenne, F Vasseur, G Savoye & D Turck. (2017) Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study. Gut 66:11, pages 1912-1917.
Crossref
Crossref
Emily Walsh, Young Wha Chah, Samantha M. Chin, Paul Lochhead, Vijay Yajnik, Vera Denmark, John J. Garber & Hamed Khalili. (2017) Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis. Inflammatory Bowel Diseases 23:11, pages 2035-2041.
Crossref
Crossref
Johan Burisch, Ryan Ungaro, Ida Vind, Michelle V Prosberg, Flemming Bendtsen, Jean-Frederic Colombel & Marianne K. Vester-Andersen. (2017) Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 11:10, pages 1200-1204.
Crossref
Crossref
Joana Torres, Flavio Caprioli, Konstantinos H. Katsanos, Triana Lobatón, Dejan Micic, Marco Zerôncio, Gert Van Assche, James C. Lee, James O. Lindsay, David T. Rubin, Remo Panaccione & Jean-Frédéric Colombel. (2016) Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 10:12, pages 1385-1394.
Crossref
Crossref
Øistein Hovde, Marte Lie Høivik, Magne Henriksen, Inger Camilla Solberg, Milada Cvancarova Småstuen & Bjørn A. Moum. (2016) Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study. Journal of Crohn's and Colitis, pages jjw193.
Crossref
Crossref
Christine N Manser, Jan Borovicka, Frank Seibold, Stephan R Vavricka, Peter L Lakatos, Michael Fried & Gerhard Rogler. (2016) Risk factors for complications in patients with ulcerative colitis. United European Gastroenterology Journal 4:2, pages 281-287.
Crossref
Crossref
H. Anzai, K. Hata, J. Kishikawa, H. Ishii, T. Nishikawa, T. Tanaka, J. Tanaka, T. Kiyomatsu, K. Kawai, H. Nozawa, S. Kazama, H. Yamaguchi, S. Ishihara, E. Sunami, J. Kitayama & T. Watanabe. (2016) Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Disease 18:3, pages O97-O102.
Crossref
Crossref
Magnus Hofrenning Wanderås, Bjørn A Moum, Marte Lie Høivik & Øistein Hovde. (2016) Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:2, pages 235.
Crossref
Crossref
Øistein Hovde, Milada C. Småstuen, Marte L. Høivik, Tomm Bernklev, Gert Huppertz-Hauss, Ole Høie, Jørgen Jahnsen, Njaal Stray, Magne Henriksen, Inger C. Solberg & Bjørn A. Moum. (2016) Mortality and Causes of Death in Ulcerative Colitis. Inflammatory Bowel Diseases 22:1, pages 141-145.
Crossref
Crossref
Bjørn Moum, Øistein Hovde & Marte Lie Høivik. (2014) What Have We Learnt about the Role of the Environment and Natural Course of IBD in the New Millennium? 20-Year Follow-Up of the IBSEN Cohort. Digestive Diseases 32:Suppl. 1, pages 2-9.
Crossref
Crossref
Ruijun Wang, Guisheng Zhou, Mengyue Wang, Ying Peng & Xiaobo Li. (2014)
The Metabolism of Polysaccharide from
Atractylodes macrocephala
Koidz and Its Effect on Intestinal Microflora
. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-7.
Crossref
Crossref